Spinal Muscular Atrophy (SMA) Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Spinal Muscular Atrophy (SMA)
argenx60 enrolled17 locationsNCT07287982
Recruiting
Not Applicable
HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Spinal Muscular Atrophy (SMA)
Teachers College, Columbia University20 enrolled1 locationNCT07488338